drug
fluocinolone acetonide SR
Marketedupdated 3mo agoby Alimera Sciences Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 6 investigational indications.
indications
investigational
Diabetic Macular Edema
all catalysts(0)
nothing on the calendar yet
Trials studying fluocinolone acetonide SR
- phase3Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
- phase4Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
- phase4Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.
- phase4A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 12, 2027
356 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Nov 7, 2028formulationUS 98490272.2y
- Jan 12, 2028formulationUS 79981081.4y
- Aug 12, 2027formulationUS 8871241356d
- Aug 12, 2027formulationUS 8871241356d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 53m ago
Found something off?
comments(0)
5-min edit window · permanent after that